Isdn 40 Retard (Isosorbide Dinitrate)

Isosorbide dinitrate is an oral nitrate vasodilator used in the management of cardiovascular conditions.

• Angina pectoris: reduces frequency and severity of chest pain episodes by decreasing myocardial oxygen demand.
• Chronic stable angina prophylaxis: provides preventive relief of exertional angina in patients with known coronary artery disease.
• Heart failure: improves symptoms by lowering preload and afterload, thereby enhancing cardiac output.

• Isosorbide dinitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP leads to relaxation of both venous and arterial vessels, producing venodilation and arterial dilation. This reduces cardiac preload and afterload, decreasing myocardial oxygen consumption and alleviating ischemic chest pain. The effect is dose‑dependent and persists with the extended‑release formulation, providing sustained hemodynamic benefit throughout the dosing interval.

Isosorbide dinitrate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: throbbing pain often occurring after the first dose.
• Flushing: warm sensation and reddening of the skin.
• Dizziness: light‑headed feeling, especially when standing quickly.
• Hypotension: low blood pressure causing faintness.
• Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure leading to syncope.
• Reflex tachycardia: rapid heart rate as a compensatory response.
• Methemoglobinemia: elevated methemoglobin causing cyanosis.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing isosorbide dinitrate, clinicians should consider several safety measures to minimize risk.

• Assess cardiovascular status: evaluate blood pressure and heart rate before initiation.
• Avoid abrupt discontinuation: taper the dose to prevent rebound angina.
• Concomitant phosphodiesterase‑5 inhibitors: contraindicated due to risk of profound hypotension.
• Hepatic or renal impairment: use with caution and monitor for accumulation.
• Pregnancy and lactation: safety not established; use only if potential benefit justifies potential risk.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Isosorbide dinitrate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Sildenafil, tadalafil, vardenafil: combined use may cause severe hypotension.
• Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood pressure fall.

Moderate Interactions (Monitor Closely)

• Antihypertensives (beta‑blockers, ACE inhibitors): may enhance blood pressure‑lowering effect.
• Diuretics: increase risk of volume depletion and hypotension.
• Alcohol: can potentiate vasodilatory response and dizziness.